Promiseb Topical Cream for Cradle Cap

Completed · Phase 4

Conditions studied: Cradle Cap, Infantile Seborrheic Dermatitis

In brief

The purpose of this study is to evaluate the efficacy and safety of Promiseb Topical Cream in cradle cap.

Key facts

Study ID

NCT01214434

Run by

Promius Pharma, LLC

People needed

42

Starts

2010-03-01

Expected to finish

2011-06-01

Last updated by the study team

2017-03-07

Who can join

Age: 0 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Clinical diagnosis of cradle cap
• Must be at least 30 days old
• Must be in good health as determined by investigator
• Naive to prior cradle cap therapy (may have used mineral, olive oils)

You may not qualify if…

• Known food, topical product or medicinal allergies.
• Prior use of corticosteroids, antifungals or keratolytics for Cradle Cap
• Weighing less than 7 lbs

Where it is running

• Norwich Pediatric Group — Norwich, Connecticut, United States
• Derm Research — Louisville, Kentucky, United States
• UMDNJ — Newark, New Jersey, United States
• Children's Hospital of Philadelphia — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.